Mental Health Screening in the Community Background The capabilities approach, as articulated by Amartya sen and Martha Nussbaum, focuses on promoting processes that enable a person to be free to do things he or she can. The 'capabilities' are a combination of individual, social, educational, economic, and political factors that can help
Author: Nivil Gopi
Bone Mineral Density Screening Combined with Mammogram
Improving Bone Mineral Density Screening by Using Digital X-Radiogrammetry (DXR) Combined With Mammography Bone Mineral Density: THE STUDY Osteoporosis is often underdiagnosed and undertreated, especially in women. In Australia, 2 in 5 women aged 50 or over will experience fragility fractures. Fractures associated with reduced bone mineral density (BMD) may cause disability
Predicting cardiovascular disease with body mass index
Predicting cardiovascular disease with Body Mass Index BMI and CVD: An Introduction Obesity, as indexed by the high body mass index (BMI), is a major risk factor for cardiovascular disease (CVD). About 60 - 80% of patients with CVD are overweight. However, there are mixed findings on the effect of decreasing BMI
Dental Screening for Cardiovascular Disease Risk
Dental Screening for Cardiovascular Disease Risk Introduction Periodontal disease (PD) is one of the most prevalent multifactorial chronic infections, affecting 46% of US adults. Though PD occurs in the 30-40 year age range, the incidence peaks at age 38 years. Atherosclerotic cardiovascular diseases (ACVD) is caused by heredity, environment, and their interactions; conventional
Ovarian adenocarcinoma with glaucoma: A case report
Ovarian adenocarcinoma with glaucoma: A case report Introduction Metastatic tumor accounts for the most common ocular malignancy in adults. In rare cases, ocular metastasis can represent the initial manifestation of an undiagnosed primary cancer such as breast and lung cancers. Patients usually present with visual field defects, ocular pain, floaters, photophobia, or
Osteopenia predicts outcomes in pancreatic cancer
Osteopenia predicts outcomes in pancreatic cancer Study Background Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer deaths in the United States and is projected to become the second by 2030. The unfavorable prognosis of PDAC can be attributed to late diagnosis, poor metabolic status, and the resistance of cancer
penile squamous cell carcinoma and human papillomavirus
penile squamous cell carcinoma and human papillomavirus Introduction The objective of this study was to to investigate the survival outcomes and prognostic factors of human papillomavirus (HPV) induced penile squamous cell carcinoma (pSCC). Penile squamous cell carcinoma (pSCC) is a rare malignancy with limited pathogenesis and carcinogenesis, and poor survival after standard treatment. They
skeletal muscle mass and cancer patient quality of life: a meta-analysis
skeletal muscle mass and cancer patient quality of life: a meta-analysis Loss of skeletal muscle mass (sarcopenia), is a widely prevalent problem among cancer patients with incidence ranging from 11 to 74%. Low skeletal muscle mass at baseline is predictive of poor cancer outcomes such as decreased overall survival, increased risk
pediatric leukemia patients utilizing levofloxacin
pediatric leukemia patients utilizing levofloxacin STUDY BACKGROUND Bacterial infection-related morbidity and mortality are high in children treated for acute myeloid leukemia (AML) and relapsed acute lymphoblastic leukemia (rALL). Bacteremia not only contributes to mortality but also prolongs hospitalization, delays chemotherapy, decreases the quality of life, and requires the administration of costly and
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC Objectives To assess the effectiveness and safety of pembrolizumab monotherapy and in combination with chemotherapy in patients with advanced non–small-cell lung cancer (NSCLC). Introduction Historically, patients with advanced NSCLC have a poor prognosis despite the use of platinum-based chemotherapy drugs. The 5-year relative survival rate of
